Expect this little research experiment of ours to be the norm. Over the next few years you’ll find the use of cannabis widespread.
Today, Brambles reported sales for the first nine months of FY17. The company generated US$4.09 billion (AU$5.42 billion), up 4% on the prior corresponding period.
We’re keeping a close eye on this ASX marijuana play. The only Aussie pot firm awarded a license to grow commercial quantities of marijuana on Canadian soil.
We’re at the start-point of a new medical age, when cannabis-derived treatments could halt cancer, cure Arthritis, stop Parkinson’s in its tracks, reduce severe epileptic seizures, and much, much more.
What really makes a car company great? Is it the profit they can make per car? Is it the amount of profit the company can make overall? Or is it innovation?
Within hours or days of receiving it, the information junkie is on to other things. The new product goes up on the shelf with the old products.
If you want your portfolio to have some potential big winners, you have to invest at the edge of understanding. That’s where the potential lies.
Viralytics Ltd [ASX:VLA] climbed 5.5% this morning to a high of $1.14 per share. VLA, as a business, is still in the early stages.
By the end in 2018 we will see the broader Aussie market north of 10,000 points. Think we’re nuts? Well, let’s see how it all plays out.
The Aussie-listed cannabis sector is up nearly 140% this year. That significantly outpaces the 20% gain for the rest of the world’s cannabis stocks.